A Retrospective study of complications of therapeutic plasma exchange in myasthenia

Muscle and Nerve

Volumn 47, Issue 2, 2013, Pages 170-176

  Guptill, Jeffrey T ^a   Oakley, Darlene ^a   Kuchibhatla, Maragatha ^a   Guidon, Amanda C ^a   Hobson Webb, Lisa D ^a   Massey, Janice M ^a   Sanders, Donald B ^a   Juel, Vern C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cohort study; Complications; Myasthenia gravis; Plasma exchange; Plasmapheresis

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARM SWELLING; ARTICLE; BACTEREMIA; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; FAINTNESS; FEMALE; HEMATOMA; HUMAN; INFORMATION PROCESSING; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYASTHENIA GRAVIS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PLASMAPHERESIS; PNEUMOTHORAX; PRIORITY JOURNAL; SEPSIS; THERAPEUTIC PLASMA EXCHANGE; THORAX PAIN; THROMBOPHLEBITIS;

ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; CENTRAL VENOUS CATHETERS; FEMALE; HEMOLYSIS; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84873049650     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23508     Document Type: Article

References (37)

1. Kaminski HJ, Cutter G, Ruff R. Practice parameters and focusing research: plasma exchange for myasthenia gravis. Muscle Nerve 2011; 43: 625-626.
2. Barth D, Nabavi NM, Ng E, Nwe P, Bril V. Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 2011; 76: 2017-2023.
3. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol 1997; 41: 789-796.
4. Qureshi AI, Choudhry MA, Akbar MS, Mohammad Y, Chua HC, Yahia AM, et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 1999; 52: 629-632.
5. Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009; 72: 1548-1554.
6. Bramlage CP, Schroder K, Bramlage P, Ahrens K, Zapf A, Muller GA, et al. Predictors of complications in therapeutic plasma exchange. J Clin Apher 2009; 24: 225-231.
7. Rodnitzky RL, Goeken JA. Complications of plasma exchange in neurological patients. Arch Neurol 1982; 39: 350-354.
8. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-1133.
9. Scott WL. Central venous catheters. An overview of Food and Drug Administration activities. Surg Oncol Clin N Am 1995; 4: 377-393.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
11. Jaretzki A, III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 2000; 70: 327-334.
12. Henze T, Prange HW, Talartschik J, Rumpf KW. Complications of plasma exchange in patients with neurological diseases. Klin Wochenschr 1990; 68: 1183-1188.
13. Reimann PM, Mason PD. Plasmapheresis: technique and complications. Intensive Care Med 1990; 16: 3-10.
14. Lehmann HC, Hartung HP, Hetzel GR, Stuve O, Kieseier BC. Plasma exchange in neuroimmunological disorders: I. Rationale and treatment of inflammatory central nervous system disorders. Arch Neurol 2006; 63: 930-935.
15. Grishaber JE, Cunningham MC, Rohret PA, Strauss RG. Analysis of venous access for therapeutic plasma exchange in patients with neurological disease. J Clin Apher 1992; 7: 119-123.
16. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 2005; 9: 391-395.
17. Couriel D, Weinstein R. Complications of therapeutic plasma exchange: a recent assessment. J Clin Apher 1994; 9: 1-5.
18. Korach JM, Petitpas D, Paris B, Bourgeade F, Passerat V, Berger P, et al. Plasma exchange in France: epidemiology 2001. Transfus Apher Sci 2003; 29: 153-157.
19. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994; 23: 817-827.
20. Puig L, Mazzara R, Torras A, Castillo R. Adverse effects secondary to the treatment with plasma exchange. Int J Artif Organs 1985; 8: 155-158.
21. Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion 1989; 29: 124-127.
22. Ziselman EM, Bongiovanni MB, Wurzel HA. The complications of therapeutic plasma exchange. Vox Sang 1984; 46: 270-276.
23. Stegmayr B, Korach JM, Norda R, Rock G, Fadel F. Is there a need for a national or a global apheresis registry? Transfus Apher Sci 2003; 29: 179-185.
24. Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, et al. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Transfus Apher Sci 2008; 38: 109-115.
25. Yucesan C, Arslan O, Arat M, Yucemen N, Ayyildiz E, Ilhan O, et al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfus Apher Sci 2007; 36: 103-107.
26. Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1, 727 procedures. J Clin Apher 2007; 22: 270-276.
27. Lazo-Langner A, Espinosa-Poblano I, Tirado-Cardenas N, Ramirez-Arvizu P, Lopez-Salmoran J, Penaloza-Ramirez P, et al. Therapeutic plasma exchange in Mexico: experience from a single institution. Am J Hematol 2002; 70: 16-21.
28. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development. JAMA 1986; 256: 1333-1337.
29. Noseworthy JH, Shumak KH, Vandervoort MK. Long-term use of antecubital veins for plasma exchange. The Canadian Cooperative Multiple Sclerosis Study Group. Transfusion 1989; 29: 610-613.
30. Mandawat A, Mandawat A, Kaminski HJ, Shaker ZA, Alawi AA, Alshekhlee A. Outcome of plasmapheresis in myasthenia gravis: delayed therapy is not favorable. Muscle Nerve 2011; 43: 578-584.
31. Pepe J. Central venous catheterization. In: Fink M, Abraham E, Vincent J, Kochanek P, editors. Textbook of critical care. Philadelphia: Elsevier Saunders, 2005. p 1785-1790.
32. Hind D, Calvert N, McWilliams R, Davidson A, Paisley S, Beverley C, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 361.
33. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 1996; 24: 2053-2058.
34. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998; 26: 1452-1457.
35. Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A. Comparative analysis of therapeutic options used for myasthenia gravis. Ann Neurol 2010; 68: 797-805.
36. Bouget J, Chevret S, Chastang C, Raphael JC. Plasma exchange morbidity in Guillain-Barre syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med 1993; 21: 651-658.
37. Rosenkvist J, Berkowicz A, Holsoe E, Sorensen H, Taaning E. Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution. Vox Sang 1984; 46: 13-18.